Burning Rock Biotech (BNR) Enterprise Value: 2019-2025
Historic Enterprise Value for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to $27.5 million.
- Burning Rock Biotech's Enterprise Value rose 173.46% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$996.4 million, marking a year-over-year decrease of 38.45%. This contributed to the annual value of -$1.9 million for FY2024, which is 121.82% down from last year.
- Per Burning Rock Biotech's latest filing, its Enterprise Value stood at $27.5 million for Q3 2025, which was up 106.54% from -$421.0 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Enterprise Value registered a high of $2.8 billion during Q2 2021, and its lowest value of -$766.2 million during Q3 2022.
- Moreover, its 3-year median value for Enterprise Value was -$37.5 million (2024), whereas its average is -$200.9 million.
- Per our database at Business Quant, Burning Rock Biotech's Enterprise Value soared by 4,549.81% in 2021 and then plummeted by 5,717.72% in 2025.
- Over the past 5 years, Burning Rock Biotech's Enterprise Value (Quarterly) stood at $758.7 million in 2021, then plummeted by 86.87% to $99.6 million in 2022, then tumbled by 91.46% to $8.5 million in 2023, then tumbled by 121.82% to -$1.9 million in 2024, then surged by 173.46% to $27.5 million in 2025.
- Its last three reported values are $27.5 million in Q3 2025, -$421.0 million for Q2 2025, and -$449.0 million during Q1 2025.